Pacira BioSciences (PCRX) Expected to Announce Earnings on Thursday

Pacira BioSciences (NASDAQ:PCRX) is expected to be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Pacira BioSciences to post earnings of $0.78 per share and revenue of $185.38 million for the quarter.

Pacira BioSciences Trading Down 2.3 %

NASDAQ:PCRX opened at $25.16 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.89 and a debt-to-equity ratio of 0.51. Pacira BioSciences has a 12 month low of $11.16 and a 12 month high of $31.67. The company has a market cap of $1.16 billion, a PE ratio of -12.39 and a beta of 0.80. The company has a 50 day simple moving average of $22.49 and a two-hundred day simple moving average of $18.31.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $18.00 target price on shares of Pacira BioSciences in a research report on Tuesday, January 14th. HC Wainwright reiterated a “buy” rating and set a $39.00 price target on shares of Pacira BioSciences in a research note on Wednesday, December 4th. Barclays dropped their price target on shares of Pacira BioSciences from $25.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 12th. Truist Financial upgraded shares of Pacira BioSciences from a “sell” rating to a “hold” rating and lifted their price target for the stock from $8.00 to $25.00 in a research note on Thursday, January 30th. Finally, Needham & Company LLC lifted their price target on shares of Pacira BioSciences from $22.00 to $30.00 and gave the stock a “buy” rating in a research note on Monday, January 13th. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $22.78.

About Pacira BioSciences

Pacira Biosciences, Inc is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.